PagSeguro Digital (NASDAQ: NH) and NantHealth (NASDAQ:NH) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends.

Profitability

This table compares PagSeguro Digital and NantHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PagSeguro Digital N/A N/A N/A
NantHealth -124.02% -49.56% -20.32%

Analyst Ratings

This is a summary of current ratings and target prices for PagSeguro Digital and NantHealth, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PagSeguro Digital 2 1 8 0 2.55
NantHealth 0 1 2 0 2.67

PagSeguro Digital currently has a consensus price target of $36.09, indicating a potential upside of 32.06%. NantHealth has a consensus price target of $4.83, indicating a potential upside of 213.85%. Given NantHealth’s stronger consensus rating and higher probable upside, analysts clearly believe NantHealth is more favorable than PagSeguro Digital.

Valuation & Earnings

This table compares PagSeguro Digital and NantHealth’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PagSeguro Digital $790.32 million 4.25 $149.95 million $0.57 47.89
NantHealth $86.68 million 1.96 -$175.21 million ($1.12) -1.38

PagSeguro Digital has higher revenue and earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than PagSeguro Digital, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

5.6% of NantHealth shares are owned by institutional investors. 64.9% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

PagSeguro Digital beats NantHealth on 9 of the 13 factors compared between the two stocks.

PagSeguro Digital Company Profile

PagSeguro Digital Ltd. provides financial technology solutions and services for micro-merchants, and small and medium-sized businesses in Brazil and internationally. The company's products and services include PagSeguro Ecosystem, an end-to-end digital ecosystem that operates as a closed loop where its clients are able to address their primary day to day financial needs, including receiving and spending funds, and managing and growing their businesses; and Free PagSeguro digital account, which centralizes various cash-in options, functionalities, services, and cash-out options in a single ecosystem. It also acquires and sells point of sale (POS) devices and other products; and offers online gaming and cross-border digital services. In addition, the company offers functionalities, and value-added services and features, such as purchase protection mechanisms, antifraud platform, account and business management tools, eWallet, and its POS app. Further, it is involved in processing of back-office solutions, including sales reconciliation, and gateway solutions and services, as well as the capture of credit cards with administrators and acquirers. Additionally, the company engages in the in-person payment activities through POS devices; and issuance of prepaid cards to clients for spending or withdrawing account balances. It also provides online gaming and cross-border digital services; and operates an online platform that facilitates peer-to-peer lending. The company was founded in 2006 and is headquartered in São Paulo, Brazil. PagSeguro Digital Ltd. is a subsidiary of Universo Online S.A.

NantHealth Company Profile

NantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Receive News & Ratings for PagSeguro Digital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PagSeguro Digital and related companies with MarketBeat.com's FREE daily email newsletter.